Skip to content

A brief GP intervention for weight loss: The BWeL-B feasibility trial

A feasibility study testing the acceptance and recruitment methods of weight loss intervention referrals to help inform the development of a larger trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN72298614
Enrollment
65
Registered
2018-06-06
Start date
2018-10-16
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Nutritional, Metabolic, Endocrine Obesity

Interventions

After GPs have dealt with the participating patient’s original presenting complaint(s), and have confirmed the appropriateness of proceeding, they will briefly deliver one of two treatments, which the

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Body mass index (BMI) >30 kg/m2 (or >25 kg/m2 for South Asian population groups) and excess body fat 2. Aged 18 years or over 3. Participant is willing and able to give informed consent for participation in the study and comply with study procedures.

Exclusion criteria

Exclusion criteria: 1. Pregnant or imminently intending to become pregnant 2. Persons with pacemakers or other electronic medical implants 3. Currently or within the past three months participated in a weight management programme (including pharmacotherapy or bariatric surgery) 4. Visiting the GP for weight management 5. GP deems it inappropriate to make an opportunistic intervention on weight management. This includes personal medical reasons known to the GP, such as an eating disorder, or reasons related to the consultation e.g. the patient has become distressed and it would seem insensitive to make such an intervention at this time. If the GP does not consider it appropriate, then the patient will not be enrolled and randomised into the trial (see section 7.5 Randomisation, blinding, and code breaking). 6. Unable to understand and speak English sufficiently to give informed consent and complete the research assessments

Design outcomes

Primary

MeasureTime frame
Attendance at weight management programme assessed using participant report via telephone at 3 weeks after the consultation.

Secondary

MeasureTime frame
1. Acceptance of GP referral immediately after the appointment, specifically whether they planned to attend the weight management programme in the immediate future (recorded immediately after the referral by the investigator). 2. Participants also rate the helpfulness and the appropriateness of the GP’s very brief intervention on five-item Likert-type scales. 3. Participants’ thoughts about the opportunistic intervention, (and the script specifically) that was delivered when they visited for reasons other than their weight. Also whether other styles may have resulted in a different reaction than the one experienced. This is assessed using a 3-week follow-up phone call via a semi-structured interview by the investigator. 4. GPs' thoughts and attitudes about the two brief intervention scripts. This will include exploring: why GPs felt as they did; whether other brief interventions might be more or less acceptable than the one they gave; and whether these interventions might be suitable for all people who are obese, or only those with relevant medical conditions. This is measured via a questionnaire pre- and post-intervention and a semi-structured interview up to 1 week post-intervention. 5. Comparison of the proportion of participants who attend a weight management programme in each treatment arm (basic cost vs cost comparison) at 3-week post-intervention follow-up.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026